Gallbladder Cancer Registry Study
Part of Cancer, Digestive system clinical trials.
This study builds a database for gallbladder cancer by collecting medical information and blood samples from patients. It helps doctors better understand the disease and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have a diagnosis of gallbladder cancer (either based on scans and lab tests, or confirmed after surgery).
- The main tumor is in your gallbladder (not spread from elsewhere).
- You are generally well enough to care for yourself (Karnofsky score above 50).
- You agree to sign a consent form, follow the study, and give blood samples.
- You are not pregnant, breastfeeding, or participating in another clinical trial that would interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a research database and a “multiomics” biobank (stored samples for lab testing) from people with benign and malignant bile duct or gallbladder conditions. It may help researchers understand these diseases better and improve future testing and treatments.
This trial is studying people with gallbladder cancer, abnormal cell changes (dysplasia), or gallstones. It aims to learn more about these conditions, possibly before or after treatment, or before gallbladder removal surgery.
This registry collects information from people with liver cancer or bile duct cancer to learn more about the disease and its treatment. Anyone 18 or older with any stage of these cancers can join.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
This study collects information from patients with different types of digestive cancers to better understand these diseases and improve future care. It does not test a new treatment, but helps doctors learn more about digestive cancers over time.
This study analyzes tumor tissue samples from patients with biliary tract cancer (a rare cancer of the bile ducts or gallbladder) to identify genetic and protein markers that may help doctors better understand and treat the disease. Your stored tissue sample and medical records would be used to find patterns that could improve future treatment options.
Hear when a new Biliary Tract Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.